Rybelsus® 3mg（Semaglutide）口服錠

Rybelsus® 3mg is an oral tablet containing semaglutide, a glucagon-like peptide-1 receptor agonist, commonly known as a GLP-1 receptor agonist. It is designed for once-daily oral use under medical supervision and is used as part of a healthcare professional-directed treatment plan.

Rybelsus® is known for its convenient tablet form, offering an oral alternative to injectable GLP-1 medicines. The 3mg strength is generally used as a starting dose to help the body adjust before further dose changes are considered by a healthcare provider.

產品資訊：

• 產品名稱： Rybelsus® 3mg（Semaglutide）口服錠
• Japanese Name: リベルサス錠3mg
• Chinese Name: Rybelsus® 3mg（Semaglutide）口服錠
• Active Ingredient: Semaglutide
• Strength: 3mg
• Dosage Form: Oral tablet
• Route of Administration: Oral
• Drug Class: GLP-1 receptor agonist
• Brand Owner: Novo Nordisk
• Product Type: Prescription medicine
• Use: Use only as directed by a licensed healthcare professional

What Is Rybelsus® 3mg?

Rybelsus® 3mg contains semaglutide in an oral tablet form. Semaglutide belongs to a class of medicines called GLP-1 receptor agonists, which act on GLP-1 receptors involved in blood sugar regulation, appetite signaling, and gastric emptying.

The 3mg tablet is commonly used as an initial starting strength. It allows patients to begin therapy at a lower dose before a healthcare professional decides whether adjustment to a higher strength is appropriate.

This product should not be used without medical advice, diagnosis, and prescription.

主要特點

Rybelsus® 3mg is known for:

• Contains semaglutide 3mg
• Once-daily oral tablet format
• Belongs to GLP-1 receptor agonist class
• Non-injectable semaglutide option
• Commonly used as a starting dose
• Manufactured by Novo Nordisk
• Prescription-only medicine
• Should be used with diet, lifestyle, and medical monitoring as advised by a healthcare provider

About Semaglutide

Semaglutide is a GLP-1 receptor agonist. GLP-1 receptor agonists are medicines that mimic the action of a naturally occurring hormone called glucagon-like peptide-1.

Under professional guidance, semaglutide may help support:

• Blood glucose control
• Insulin response after meals
• Reduced glucagon secretion when blood sugar is elevated
• Slower gastric emptying
• Appetite regulation signals

The actual effect and suitability depend on the patient’s medical condition, current medications, and physician assessment.

Starting Dose Information

The 3mg strength is typically considered an initial dose for treatment initiation.

This starting dose helps the body gradually adapt to semaglutide and may help reduce gastrointestinal discomfort when beginning therapy.

Dose escalation or switching to a different strength should only be done according to a doctor’s instruction.

How to Take Rybelsus® 3mg

Use exactly as directed by your doctor or pharmacist.

General administration guidance may include:

• Take once daily by mouth.
• Take on an empty stomach after waking.
• Take with a small amount of plain water.
• Wait before eating, drinking, or taking other oral medicines.
• Do not split, crush, or chew the tablet.
• Follow your prescribed dosing schedule carefully.

Always follow the official prescription label and healthcare provider instructions.

Who May Be Prescribed Rybelsus®?

Rybelsus® may be prescribed by a healthcare professional for suitable adult patients who require GLP-1-based therapy as part of a medical treatment plan.

A doctor will assess factors such as:

• Medical history
• Blood sugar levels
• Weight and metabolic profile
• Current medications
• Kidney and liver function
• Digestive system history
• Pregnancy or fertility plans
• Risk of side effects

This medicine is not suitable for everyone.

Important Safety Information

Do not use Rybelsus® without medical supervision.

Before using this medicine, tell your healthcare provider if you:

• Have a history of pancreatitis
• Have severe stomach or intestinal problems
• Have kidney disease
• Have liver disease
• Have diabetic retinopathy
• Are pregnant, planning pregnancy, or breastfeeding
• Are taking insulin or sulfonylurea medicines
• Have a history of thyroid tumors or endocrine disorders
• Have allergies to semaglutide or any ingredient in the tablet

可能的副作用

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort
• Loss of appetite
• Indigestion
• Bloating
• Fatigue

Serious side effects may occur rarely and require medical attention.

Seek medical help immediately if you experience:

• Severe or persistent abdominal pain
• Signs of pancreatitis
• Severe vomiting or dehydration
• Allergic reaction
• Vision changes
• Symptoms of low blood sugar, especially if used with insulin or sulfonylurea
• Neck lump, difficulty swallowing, or persistent hoarseness

貯存

Store according to the product package and pharmacist instructions.

General storage recommendations:

• Keep in original packaging.
• Protect from moisture.
• Store at room temperature unless otherwise stated.
• Keep away from children and pets.
• Do not use after the expiry date.

重要說明

• Rybelsus® is a prescription medicine.
• Use only under doctor supervision.
• Do not share this medicine with others.
• Do not use for cosmetic weight loss without medical indication.
• Do not change dose without medical advice.
• It is not a substitute for diet, exercise, or diabetes care.
• Individual results and tolerability vary.

Disclaimer

This product page is for general product information only and does not replace professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.